-transparent.png){kind=logo}
Hemoperfusion with activated charcoal is indicated in intoxications and in hepatic comma because the charcoal absorbs toxic substances. Good results have been obtained so far with activated charcoal liver perfusion in barbiturate intoxications, but less satisfactory results in hepatic comma. The indication for perfusion should also be made in clinically hopeless cases. The principal complications with activated charcoal perfusion are a decrease in thrombocytes and microemboli of charchoal particles. These complications can be avoided by coating the charcoal particles. A flow-rate of 200-300 ml/min is best in humans because this flow-rate ist guaranteed by an AV shunt in the forearm.
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
January 1982,
Nihon rinsho. Japanese journal of clinical medicine,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
March 1985,
Orvosi hetilap,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
January 1975,
Eksperimental'naia khirurgiia i anesteziologiia,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
January 1987,
Vutreshni bolesti,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
November 1980,
Clinical toxicology,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
June 2002,
Anales de medicina interna (Madrid, Spain : 1984),
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
January 1977,
Acta pharmacologica et toxicologica,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
January 1977,
Terapevticheskii arkhiv,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
April 1988,
Revista clinica espanola,
T S Lie, and
W I Kim, and
K Rommelsheim, and
A Holst
October 1980,
Schweizerische medizinische Wochenschrift,
